"They could have given a little more assurance as to what was being done here," said Dr. John Gearhart of Johns Hopkins -– one of the authors of a successful study released last week in which stem cells were created from dead human embryos. ACT's experiment is raising eyebrows because cows and humans took separate evolutionary paths more than 10 million years ago; the two cell nuclei are so different that they're unlikely to stick together for long. "There's no reason to believe this thing would get past a few cell divisions," says Elmer-DeWitt.
ACT claims it went public now to gauge the acceptability of such research and to help decide whether to commit money to it. But peer review is going to be tough, given that it's unlikely that any serious scientific journal will publish ACT's skimpy material as it stands. Nor will the market make anything out of it -- ACT has no IPO on the horizon.